MYX vs NSB

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

MYX

M PHARMA FPO [MYX]

51MEDIUM

NSB

NEUROSCIEN FPO [NSB]

49LOW

Score Breakdown

MYX NSB
Technical
51
49
Catalyst
53
53
Sentiment
50
50
Fundamental
85
87
Momentum
38
36
Risk Gate
42
46

Key Metrics

MYX Metric NSB
$233.2MMarket Cap$27.7M
291KAvg Volume (20d)301K
+2.5%Short InterestN/A
$6.50052-Week High$0.260
$2.04052-Week Low$0.055
-0.7%Daily Change-4.2%
$2.810Reference Price$0.068
-20.6%ROE-29.6%
-20.4%Profit MarginN/A

Active Signals

MYX Signals

Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.6x)
EPS estimates revised upward (+10pts)
Near 52-week low (19% of range)
CANSLIM I: Institutional ownership (36%)
Deeply negative margins (-20%)

NSB Signals

Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Beating the Small Ords index — relative strength of 1.11, so it's outpacing the pack
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Volatility is expanding fast — choppy price action, so buckle up
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (18 quarters)
Very high P/S ratio (87.0x)
Strong revenue growth (+129%)

Ask Scout AI to compare MYX and NSB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

MYX vs NTI →MYX vs OCC →MYX vs PAR →MYX vs RCE →MYX vs VIT →
MYX Full Analysis → NSB Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).